TLR2/TLR4-dependent exaggerated cytokine production in hyperimmunoglobulinaemia D and periodic fever syndrome (Q40193922)

18 September 2017

TLR2/TLR4-dependent exaggerated cytokine production in hyperimmunoglobulinaemia D and periodic fever syndrome (English)

1 reference

18 September 2017

0 references

6

1 reference

18 September 2017

Jos W. M. van der Meer,

5

object named as

Jos W M van der Meer

1 reference

18 September 2017

Monique Stoffels

1

1 reference

18 September 2017

Johanna Jongekrijg

2

1 reference

18 September 2017

Thijs Remijn

3

1 reference

18 September 2017

Nina Kok

4

1 reference

18 September 2017

29 August 2014

1 reference

18 September 2017

1 reference

18 September 2017

54

1 reference

18 September 2017

363-368

1 reference

18 September 2017

2

1 reference

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

18 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU341

Mevalonate kinase deficiency nomenclature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU341

Hyper-IgD syndrome or mevalonate kinase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU341

Mutations in the mevalonate kinase (MVK) gene cause nonsyndromic retinitis pigmentosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU341

Exome sequencing identifies MVK mutations in disseminated superficial actinic porokeratosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU341

On-demand anakinra treatment is effective in mevalonate kinase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU341

Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU341

Compromized geranylgeranylation of RhoA and Rac1 in mevalonate kinase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU341

HMG-CoA reductase inhibition induces IL-1beta release through Rac1/PI3K/PKB-dependent caspase-1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU341

Statin synergizes with LPS to induce IL-1beta release by THP-1 cells through activation of caspase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU341

The inhibition of mevalonate pathway induces upregulation of NALP3 expression: new insight in the pathogenesis of mevalonate kinase deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU341

Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU341

Defective apoptosis of peripheral-blood lymphocytes in hyper-IgD and periodic fever syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU341

Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU341

Defects in mitochondrial clearance predispose human monocytes to interleukin-1β hypersecretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU341

Endogenous toll-like receptor ligands and their biological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEU341

10.1093/RHEUMATOLOGY/KEU341

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference